HCV NS3 protease inhibitors
US7879797B2 · kind B2 · utility
6Cited by
6References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2006 |
| Grant date | Feb 1, 2011 |
| Priority date | — |
| Expiry date | Aug 31, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/0821
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.